17
Dec
2025
A trial report concludes that ivermectin for COVID-19 is unlikely to provide clinically meaningful improvement in recovery or hospital admissions.
So this is their take home message from the paper. It says ivermectin for COVID-19 is unlikely to provide a clinically meaningful improvement in recovery, hospital admissions or longer term outcomes. Further trials of ivermectin for SARS-CoV-2 infection in vaccinated community populations appear unwarranted.